Novo Nordisk Stock Rises as Q4 Wegovy Sales More Than Double
Novo Nordisk's U.S.-listed shares rose 5% in intraday trading after the Ozempic and Wegovy maker's better-than-estimated ...
Novo Nordisk missed its diversity targets last year, and its CEO paid a financial price
Novo Nordisk's CEO took a $1.5 million pay cut in 2024 as the pharma giant's share price tanked and it missed profit and DEI ...
AOL8d
Novo Nordisk missed its diversity targets last year, and its CEO paid a financial price
Jørgensen also faced a qualitative assessment on his personal performance as CEO, where he hit 50% of his maximum remuneration for his individual performance. Novo Nordisk's CFO, Karsten Munk ...